V022-1101 Screening compound: N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

V022-1101 Screening compound: N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide
V022-1101 Screening compound: N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-1101
N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-1101

Molecular Formula

C31H25FN4O3 (C31 H25 FN4 O3)

Compound Name

N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

IUPAC name

N-benzyl-4-{[2-(4-fluorophenyl)-5-(2-methylphenoxy)-3-oxo-23-dihydropyridazin-4-yl]amino}benzamide

SMILES

Cc(cccc1)c1OC(C=NN(c(cc1)ccc1F)C1=O)=C1Nc(cc1)ccc1C(NCc1ccccc1)=O

InChI

InChI=1S/C31H25FN4O3/c1-21-7-5-6-10-27(21)39-28-20-34-36(26-17-13-24(32)14-18-26)31(38)29(28)35-25-15-11-23(12-16-25)30(37)33-19-22-8-3-2-4-9-22/h2-18,20,35H,19H2,1H3,(H,33,37)

InChI Key

YXTLFPPEWBBHRQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19836123

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

520.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.166

Distribution Coefficient, logD

5.139

Water Solubility, LogSw

-5.14

Polar Surface Area

67.816

Acid Dissociation Constant (pKa)

10.09

Base Dissociation Constant (pKb)

6.19

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.50

V022-1101 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-1101 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-1101?
Check Price and Availability of V022-1101, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-1101 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-1101
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-1101
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-1101 available by request